Comparing a novel Catfish flow restoration device and the Solitaire stent retriever for thrombectomy revascularisation in emergent largevessel occlusion stroke: a prospective randomised controlled study

• Published in: Stroke and vascular neurology Vol. 8; no. 6; pp. 435 - 443
• Main Authors: Luo, Gang, Yan, Xiaoyan, Xiao, Guodong, Wei, Liping, Nai bi jiang, Ya li kun, Ma, Rongyao, Chen, Wenhuo, Fang, Chun, Zhou, Zhiming, Wan, Jieqing, Peng, Ya, Zhang, Guilian, Zhao, Junfeng, Li, Li, Yuan, Haicheng, Wu, Jin, Li, Bing, Zhang, Fan, Cheng, Yuhong, Gao, Feng, Miao, Zhongrong
• Format: Journal Article
• Language: English
• Published: England BMJ Publishing Group Ltd 01.12.2023; BMJ Publishing Group LTD; BMJ Publishing Group
• Subjects: Arterial Occlusive Diseases; Blood pressure; Brain Ischemia - diagnostic imaging; Brain Ischemia - surgery; Cerebral Infarction; Clinical Trial; Humans; Intervention; Ischemia; Ischemic Stroke - complications; Ischemic Stroke - diagnostic imaging; Ischemic Stroke - therapy; Laboratories; Medical imaging; Original Research; Patients; Prospective Studies; Statistical analysis; Stents; Stents - adverse effects; Stroke; Stroke - complications; Stroke - diagnostic imaging; Stroke - therapy; Thrombectomy; Treatment Outcome; United States; Veins & arteries; United States; China; Intervention; Stroke; Thrombectomy; Cerebral Infarction; Clinical Trial
• ISSN: 2059-8688; 2059-8696
• DOI: 10.1136/svn-2022-002036

BackgroundThe Catfish stent retriever is a newly developed mechanical thrombectomy device for rapid recanalisation in emergent large vessel occlusion (ELVO) stroke. The current trial aimed to assess whether the Catfish stent retriever is non-inferior to the Solitaire stent retriever in terms of outcomes in ELVO stroke.MethodsThis was a randomised, prospective, parallel-group, multicentre, open-label, non-inferiority study conducted at 18 sites in China. The primary outcome was the proportion of cases with successful recanalisation (modified thrombolysis in cerebral infarction score of 2b or 3) following the procedure. Secondary efficacy outcomes included the National Institutes of Health Stroke Scale scores at 24 hours and 7 days or discharge if earlier, time from artery puncture to successful recanalisation and good clinical outcome (modified Rankin scale score ≤2) at 90 days. Safety outcomes included symptomatic intracranial haemorrhage, all cause-death and severe adverse events at 90 days.ResultsBetween 3 March 2019 and 5 June 2021, 118 and 120 patients were randomly allocated to the Catfish and Solitaire groups, respectively. The primary endpoint after all endovascular procedures was non-inferior in the Catfish group (88.5%, 100/113) than in the Solitaire group (87.7%, 100/114), with a rate difference (RD) of 0.78% (95% CI –7.64 to –9.20; p=0.001). Sensitivity analysis only considering the per-protocol set also yielded similar results, with an RD of 0.83% (95% CI –7.03 to –8.70; p<0.001). Additionally, the proportions of cases with good clinical outcomes (47.8% vs 50.0%, p=0.739) and all-cause death rates (17.7% vs 18.8%, p=0.700) were similar in both groups at 90 days.ConclusionsThe Catfish stent retriever is an effective and safe device for endovascular recanalisation in ELVO stroke.Trial registration number NCT03820882.